2016
DOI: 10.1007/s00384-015-2479-0
|View full text |Cite
|
Sign up to set email alerts
|

Study on colorectal cancer presentation, treatment and follow-up

Abstract: Our study shows that the mean age group at risk for colorectal cancer is 65 years (range 54-75). Still, 33 % of patients present to acute surgical assessment units with advanced disease. Though we did well in terms of operative resections, follow-up still remains a challenge.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
9
0
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 0 publications
1
9
0
1
Order By: Relevance
“…Colorectal cancer is one of the most common digestive tract malignancies worldwide, with a poor prognosis ( 23 ). Apoptosis or programmed cell death (PCD) is a mechanism of nucleated cell death, which is regulated by physiological processes, including alterations to the intracellular and extracellular environments or cell death signaling activation.…”
Section: Discussionmentioning
confidence: 99%
“…Colorectal cancer is one of the most common digestive tract malignancies worldwide, with a poor prognosis ( 23 ). Apoptosis or programmed cell death (PCD) is a mechanism of nucleated cell death, which is regulated by physiological processes, including alterations to the intracellular and extracellular environments or cell death signaling activation.…”
Section: Discussionmentioning
confidence: 99%
“…Patients who have been diagnosed with early stage CRC frequently are treated with surgery in conjunction with chemotherapy and radiotherapy to improve their survival rate (1). However, for the majority of patients diagnosed with CRC have already reached an advanced pathological stage, chemotherapy is the major form of treatment (5)(6)(7)(8). In particular, 5-fluorouracil (5-FU)-based regimens are used as the international standard for late-stage CRC treatment (9,10).…”
Section: Introductionmentioning
confidence: 99%
“…Colorectal cancer (CRC) ranked the third of cancer incidence and the fourth of cancer death in 2013 [ 1 ]. A large number of deaths occurred in CRC patients owing to no effective approach for the cure of advanced CRC [ 2 , 3 ]. Although an increasing number of oncogenes have been reported to be responsible for the development of CRC, such as S100P [ 4 ], K-Ras [ 5 ] and BRAF [ 6 ], efforts are still needed to clarify the molecular mechanisms of migration and invasion of advanced CRC.…”
Section: Introductionmentioning
confidence: 99%